{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:59:22Z","timestamp":1756810762801,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10072-022-06367-3","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T03:16:42Z","timestamp":1661743002000},"page":"361-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Primary central nervous system lymphoma in a patient with multiple sclerosis using fingolimod"],"prefix":"10.1007","volume":"44","author":[{"given":"Matheus Bernardon","family":"Morillos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Henrique Pires","family":"de Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Roberto","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana \u00c1vila","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4720-4601","authenticated-orcid":false,"given":"Cristian Daniel","family":"Piccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Finkelsztejn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"6367_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.critrevonc.2017.03.019","volume":"113","author":"G Citterio","year":"2017","unstructured":"Citterio G, Reni M, Gatta G, Ferreri AJM (2017) Primary central nervous system lymphoma. Crit Rev Oncol Hematol 113:97\u2013110. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.03.019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"6367_CR2","doi-asserted-by":"publisher","first-page":"e00362","DOI":"10.1002\/brb3.362","volume":"5","author":"N Garg","year":"2015","unstructured":"Garg N, Smith TW (2015) An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav. 5(9):e00362. https:\/\/doi.org\/10.1002\/brb3.362","journal-title":"Brain Behav."},{"issue":"59","key":"6367_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-pharmtox-010818-021358","volume":"6","author":"J Chun","year":"2019","unstructured":"Chun J, Kihara Y, Jonnalagadda D, Blaho VA (2019) Fingolimod: lessons learned and new opportunities for treating multiple sclerosis and other disorders. Annu Rev Pharmacol Toxicol 6(59):149\u2013170. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010818-021358","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"6367_CR4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1080\/10428194.2019.1691197","volume":"61","author":"H Kawai","year":"2020","unstructured":"Kawai H, Matsushita H, Akashi H, Furuya D, Kawakami S, Suzuki R, Moriuchi M, Ogawa Y, Kawada H, Nakamura N, Ando K (2020) Peripheral T-cell lymphomas as fingolimod-associated lymphoproliferative disorder for patients with multiple sclerosis - case report with literature review. Leuk Lymphoma 61(4):959\u2013962. https:\/\/doi.org\/10.1080\/10428194.2019.1691197","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"6367_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/bjh.16222","volume":"188","author":"P Mahale","year":"2020","unstructured":"Mahale P, Herr MM, Engels EA, Pfeiffer RM, Shiels MS (2020) Autoimmune conditions and primary central nervous system lymphoma risk among older adults. Br J Haematol. 188(4):516\u2013521. https:\/\/doi.org\/10.1111\/bjh.16222","journal-title":"Br J Haematol."},{"key":"6367_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.msard.2017.11.012","volume":"19","author":"N Manouchehri","year":"2018","unstructured":"Manouchehri N, Mirmosayyeb O, Badihian S, Shaygannejad V (2018) Cutaneous anaplastic large cell lymphoma in a multiple sclerosis patient receiving fingolimod. Mult Scler Relat Disord 19:121\u2013123. https:\/\/doi.org\/10.1016\/j.msard.2017.11.012","journal-title":"Mult Scler Relat Disord"},{"key":"6367_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.msard.2017.11.014","volume":"19","author":"DW Stitt","year":"2018","unstructured":"Stitt DW, Boes CJ, Flanagan EP, Howard MT, Colgan JP (2018) A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimod. Mult Scler Relat Disord 19:115\u2013117. https:\/\/doi.org\/10.1016\/j.msard.2017.11.014","journal-title":"Mult Scler Relat Disord"},{"key":"6367_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102776","volume":"49","author":"JA Chacko","year":"2021","unstructured":"Chacko JA, Strati P, Stout PW, Archer RL, Baltz BP, Chacko JG (2021) Primary mediastinal large B-cell lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis. Mult Scler Relat Disord 49:102776. https:\/\/doi.org\/10.1016\/j.msard.2021.102776","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"6367_CR9","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1097\/IOP.0000000000000774","volume":"33","author":"KL Christopher","year":"2017","unstructured":"Christopher KL, Elner VM, Demirci H (2017) Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis. Ophthalmic Plast Reconstr Surg. 33(3):e73\u2013e75. https:\/\/doi.org\/10.1097\/IOP.0000000000000774","journal-title":"Ophthalmic Plast Reconstr Surg."},{"issue":"13","key":"6367_CR10","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/1352458518774444","volume":"24","author":"A Froehlich","year":"2018","unstructured":"Froehlich A, Schmidt S, Landsberg J, Bieber T, Wenzel J (2018) Spontaneous regression of tumor-stage cutaneous T-cell lymphoma in a multiple sclerosis patient after discontinuing fingolimod. Mult Scler 24(13):1785\u20131787. https:\/\/doi.org\/10.1177\/1352458518774444","journal-title":"Mult Scler"},{"issue":"14","key":"6367_CR11","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1177\/1352458516645868","volume":"22","author":"D Papathemeli","year":"2016","unstructured":"Papathemeli D, Gr\u00e4fe R, Hildebrandt U, Zettl UK, Ulrich J (2016) Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod. Mult Scler 22(14):1888\u20131890. https:\/\/doi.org\/10.1177\/1352458516645868","journal-title":"Mult Scler"},{"issue":"1","key":"6367_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1352458515597568","volume":"22","author":"AP Samaraweera","year":"2016","unstructured":"Samaraweera AP, Cohen SN, Akay EM, Evangelou N (2016) Lymphomatoid papulosis: a cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis. Mult Scler 22(1):122\u2013124. https:\/\/doi.org\/10.1177\/1352458515597568","journal-title":"Mult Scler"},{"issue":"14","key":"6367_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2377-14-21","volume":"29","author":"J Kira","year":"2014","unstructured":"Kira J, Itoyama Y, Kikuchi S, Hao Q, Kurosawa T, Nagato K, Tsumiyama I, von Rosenstiel P, Zhang-Auberson L, Saida T (2014) Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension. BMC Neurol 29(14):21. https:\/\/doi.org\/10.1186\/1471-2377-14-21","journal-title":"BMC Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06367-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06367-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06367-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T04:59:31Z","timestamp":1672981171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06367-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["6367"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06367-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"27 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a retrospective and observational case report and is not applicable for the ethics committee approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written declaration of consent was obtained from the family.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}